期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Are liver nested stromal epithelial tumors always low aggressive?
1
作者 Tania Meletani Luca Cantini +12 位作者 Andrea Lanese Daniele Nicolini alessia cimadamore Andrea Agostini Giulia Ricci Stefania Antognoli Alessandra Mandolesi Maria Guido Rita Alaggio Gian Marco Giuseppetti Marina Scarpelli Marco Vivarelli Rossana Berardi 《World Journal of Gastroenterology》 SCIE CAS 2017年第46期8248-8255,共8页
Nested stromal-epithelial tumor(NSET) is a nonhepatocytic and non-biliary tumor of the liver consisting of nests of epithelial and spindled cells with associated myofibroblastic stroma and variable intra-lesional calc... Nested stromal-epithelial tumor(NSET) is a nonhepatocytic and non-biliary tumor of the liver consisting of nests of epithelial and spindled cells with associated myofibroblastic stroma and variable intra-lesional calcification and ossification, which represents a very rare and challenging disease. Most of the reported cases have been treated with surgery, obtaining a long survival outcome. Here, we report the case of a 31-year-old Caucasian man who underwent surgery at our institution for a large, lobulated, multinodular mass of the right hemi-liver. The histological exam confirmed the diagnosis of NSET. After 6 mo from surgery, a liver recurrence was described and a chemoembolization was performed. After a further disease progression, based on the correlation between the histological features of the disease and those of the hepatoblastoma, a similar chemotherapy regimen(with cisplatin and ifosfamide/mesna chemotherapy, omitting doxorubicin due to liver impairment) was administered. However, infection of the biliary catheter required a dose modification of the treatment. No benefit was noted and a progression of disease was radiologically assessed after only four cycles. The worsening of the clinical status prevented further treatments, and the patient died a few months later. This case report documents how the NSET might have an aggressive and non-preventable behavior. No chemotherapy schedules with a proved efficacy are available, and new data are needed to shed light on this rare neoplasm. 展开更多
关键词 Nested stromal epithelial tumor LIVER RARE Chemotherapy AGGRESSIVE METASTATIC
暂未订购
Artificial intelligence in prostate cancer
2
作者 Wei Li Ruoyu Hu +11 位作者 Quan Zhang Zhangsheng Yu Longxin Deng Xinhao Zhu Yujia Xia Zijian Song alessia cimadamore Fei Chen Antonio Lopez-Beltran Rodolfo Montironi Liang Cheng Rui Chen 《Chinese Medical Journal》 2025年第15期1769-1782,共14页
Prostate cancer(PCa)ranks as the second most prevalent malignancy among men worldwide.Early diagnosis,personalized treatment,and prognosis prediction of PCa play a crucial role in improving patients’survival rates.Th... Prostate cancer(PCa)ranks as the second most prevalent malignancy among men worldwide.Early diagnosis,personalized treatment,and prognosis prediction of PCa play a crucial role in improving patients’survival rates.The advancement of artificial intelligence(AI),particularly the utilization of deep learning(DL)algorithms,has brought about substantial progress in assisting the diagnosis,treatment,and prognosis prediction of PCa.The introduction of the foundation model has revolutionized the application of AI in medical treatment and facilitated its integration into clinical practice.This review emphasizes the clinical application of AI in PCa by discussing recent advancements from both pathological and imaging perspectives.Furthermore,it explores the current challenges faced by AI in clinical applications while also considering future developments,aiming to provide a valuable point of reference for the integration of AI and clinical applications. 展开更多
关键词 Prostate cancer Artificial intelligence Whole-slide image PATHOLOGY Foundation model IMAGING
原文传递
Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review 被引量:1
3
作者 Ilaria Fiordoliva Giulia Marcantognini +3 位作者 Silvia Rinaldi alessia cimadamore Rodolfo Montironi Rossana Berardi 《Journal of Cancer Metastasis and Treatment》 2019年第7期69-76,共8页
Syndrome of inappropriate antidiuresis (SIAD) is a common paraneoplastic syndrome commonly associated with thoracic malignancies, gastrointestinal cancers and kidney tumors. It is defined as hyponatremia in euvolemic ... Syndrome of inappropriate antidiuresis (SIAD) is a common paraneoplastic syndrome commonly associated with thoracic malignancies, gastrointestinal cancers and kidney tumors. It is defined as hyponatremia in euvolemic patients, often due to abnormal secretion of antidiuretic hormone by tumor cells. Tolvaptan, a vasopressin-2-receptor antagonist, is currently recommended for patients affected by SIAD with mild or moderate symptoms. Among patients with prostatic cancer, SIAD represents a rare condition but it is frequently associated with poorly differentiated adenocarcinoma or pure small-cell carcinoma histotype. We report a case of SIAD appeared at disease progression in a 60-year-old male patient with acinar adenocarcinoma with neuroendocrine differentiation together with a literature review. 展开更多
关键词 HYPONATREMIA prostate cancer syndrome of inappropriate antidiuresis neuroendocrine differentiation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部